BRIAN PULAYYA: Open Payments
NPI 1780126839 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 78 payments from 10 companies in 2025. Trend: 2023 $296 · 2024 $684 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $292 |
| Janssen Biotech, Inc. | 14 | $234 |
| Lilly USA, LLC | 10 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $162 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $136 |
| Regeneron Healthcare Solutions, Inc. | 6 | $133 |
| GENZYME CORPORATION | 4 | $96 |
| QOL Medical, LLC | 4 | $89 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: TREMFYA, DUPIXENT, OMVOH, ENTYVIO, XIFAXAN, RINVOQ, Sucraid, LINZESS.
Industry payments across FL — which companies pay providers there.
